MedPath

Characterization of Methylation Patterns in Lung Cancer (Lung-RND-001)

Completed
Conditions
lung cancer
10038666
Registration Number
NL-OMON45678
Lead Sponsor
ucleix Ltd.
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
200
Inclusion Criteria

Males and females
Test group: subjects18 years and above with a suspicion of a cancerous tumor in the lungs or patients who have already been diagnosed with lung cancer, however did not yet undergo surgery and did not yet receive any treatment for the cancer (including, but not limited to chemotherapy and/or radiation).
Control group: Smokers (currently or in the past) 50 years and above without cancer (current or previous) with preference to subjects which also diagnosed with COPD.

Exclusion Criteria

Test group: Subjects with cancer or history of cancer from any kind (besides lung cancer).
Control group: Subjects with cancer or history of cancer from any kind.

Study & Design

Study Type
Observational invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>Methylation patterns that are unique to lung cancer.</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>None</p><br>
© Copyright 2025. All Rights Reserved by MedPath